Phase 2 trial - New England Journal of Medicine, 2023 Average drop in liver fat after 24 weeks in a smaller fatty-liver sub-study, measured against each person's starting level
Safety Considerations and Clinical Decision-Making Both glutathione and milk thistle are generally well tolerated at recommended doses in healthy populations
The dual GIP/GLP-1 mechanism of tirzepatide creates a slightly different side effect pattern
We have demonstrated the beneficial effect of G49, a dualAG, in resolving metabolic-dysfunction associated steatohepatitis (MASH) and improving liver regeneration under this pathological condition in C57BL/6J mice by targeting multiple homeostatic mechanisms including inflammation, oxidative/endoplasmic reticulum stress, mitochondrial dysfunction, and shifting glucose metabolism 13
This produces modest, progressive fat loss without the targeted visceral specificity that makes tesamorelin unique